secwatch.observer — SEC 8-K summary
======================================

Issuer:     Viridian Therapeutics, Inc.\DE (VRDN)
CIK:        0001590750
Form:       8-K
Filed at:   2023-03-10T23:59:59+00:00
Accession:  0001193125-23-067504
Event type: other_material
Sentiment:  negative
Materiality: 0.40
Item codes: 7.01
LLM model:  deepseek-v4-flash:cloud@v2

Viridian Therapeutics discloses de minimis cash holdings at Silicon Valley Bank
-------------------------------------------------------------------------------

- Company holds low single digit millions of USD in cash and equivalents at Silicon Valley Bank.
- Disclosure made on March 10, 2023, amid SVB's collapse.
- Amount is described as de minimis, indicating limited exposure.
- Item 7.01 Regulation FD Disclosure filed with SEC as an 8-K.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1590750/000119312523067504/0001193125-23-067504-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1590750/000119312523067504/d354375d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-067504

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer